Purpose: Non-infectious uveitis is a leading cause of vision loss in the developed world. The
purpose of this systematic review is to investigate the epidemiology and risk factors of non …

The adverse events of the nitrogen-containing bisphosphonates are reviewed. Oral
bisphosphonates (alendronate, risedronate and ibandronate), mainly used for the treatment …

Use of bisphosphonates has been growing steadily in the last decade. This follows the
introduction of simpler dosing regimes, the availability of lower-priced generics, and …

Bisphosphonates are one of the most well studied groups of medications and they are bone
specific. This tissue specificity is a rare property for a drug introduced into clinical practice as …

In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

Drugs in the bisphosphonate class are the most commonly prescribed therapeutic agents for
the treatment of osteoporosis. Prospective, randomized, placebo-controlled clinical trials …

Scleral inflammatory disorders, with their extensive differential diagnoses and sometimes as
controversial treatment options, pose both diagnostic and clinical challenges for physicians …

Medication-related osteonecrosis of the jaw (MRONJ), a severe side effect caused by
antiresorptive antiangiogenic medication, particularly bisphosphonates (BPs), has become a …

Compared with the reduction in classical osteoporotic fractures, the risk of harm caused by
bisphosphonates is low, according to information presently available from clinical trials and …

Large population-based health administrative databases, clinical registries, and data
linkage systems are a rapidly expanding resource for health research. Ophthalmic research …